BioSpace News Archive

Eisai Co., Ltd. announced that the latest data on its antiepileptic drugs (AED) perampanel (product name: Fycompa) and rufinamide (product name: Inovelon, U.S. product name: BANZEL) will be presented at the 2018 Annual American Academy of Neurology (AAN) Meeting to be held from April 21 to 27, 2018 in Los Angeles, California in the United States.

September 12, 2017, Centene Corporation and Fidelis Care entered into an Asset Purchase Agreement

SCYNEXIS, Inc. announced data presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 21-24, 2018, in Madrid, Spain.

Continued progress in R&D whole-product solutions pipeline

Results underscore need for greater awareness of non-movement symptoms this Parkinson’s Disease Awareness Month

Canon BioMedical signs distribution agreement for the US and Canadian markets with Molecular Biology Systems

LABORIE Medical Technologies (“LABORIE”) and Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”) today announced the completion of the acquisition by LABORIE of Cogentix through LABORIE’S affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”)

Patients with relapsing multiple sclerosis who switched to Sanofi Genzyme’s Aubagio® (teriflunomide) from interferon therapy experienced improvements in treatment satisfaction, according to investigational data from two clinical studies.

System combines innovative cooling technology with safe, consistent methods for cold ischemic storage and transport of donor hearts to recipients for implantation.

Brexanolone IV submission is the Company’s first New Drug Application